IRIS
VILLANI, ROSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.839
EU - Europa 3.844
AS - Asia 2.657
Continente sconosciuto - Info sul continente non disponibili 582
SA - Sud America 477
AF - Africa 66
OC - Oceania 2
Totale 12.467
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.705
SG - Singapore 1.050
IE - Irlanda 914
IT - Italia 702
CN - Cina 666
RU - Federazione Russa 595
SE - Svezia 451
BR - Brasile 384
UA - Ucraina 369
HK - Hong Kong 302
FR - Francia 242
VN - Vietnam 193
DE - Germania 188
BD - Bangladesh 102
FI - Finlandia 101
IN - India 100
GB - Regno Unito 99
CA - Canada 49
AT - Austria 44
TR - Turchia 41
ID - Indonesia 36
AR - Argentina 35
MX - Messico 31
PL - Polonia 27
NL - Olanda 26
BE - Belgio 19
JP - Giappone 19
IQ - Iraq 18
ZA - Sudafrica 18
CZ - Repubblica Ceca 15
PK - Pakistan 15
VE - Venezuela 15
CO - Colombia 14
TH - Thailandia 14
AE - Emirati Arabi Uniti 12
PH - Filippine 12
SA - Arabia Saudita 11
HN - Honduras 10
RO - Romania 10
UZ - Uzbekistan 10
EG - Egitto 9
IL - Israele 9
CL - Cile 8
CR - Costa Rica 8
EC - Ecuador 8
JM - Giamaica 7
KE - Kenya 7
LT - Lituania 7
ES - Italia 6
MA - Marocco 6
PY - Paraguay 6
EU - Europa 5
GT - Guatemala 5
HU - Ungheria 5
JO - Giordania 5
LB - Libano 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
DZ - Algeria 4
IR - Iran 4
KG - Kirghizistan 4
MY - Malesia 4
PR - Porto Rico 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
GR - Grecia 3
KR - Corea 3
NI - Nicaragua 3
NP - Nepal 3
PE - Perù 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BF - Burkina Faso 2
BO - Bolivia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GE - Georgia 2
KZ - Kazakistan 2
OM - Oman 2
RS - Serbia 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CY - Cipro 1
DK - Danimarca 1
GN - Guinea 1
Totale 11.868
Salva come PNG Salva come JPEG
Città #
San Jose 962
Dublin 912
Singapore 513
Ashburn 369
Nyköping 308
Hong Kong 299
Chandler 251
Dallas 241
Jacksonville 218
Beijing 196
Santa Clara 177
Council Bluffs 164
Columbus 146
Lauterbourg 116
Wilmington 113
New York 109
Dearborn 104
Princeton 95
Moscow 75
The Dalles 75
Helsinki 73
Ho Chi Minh City 57
Nanjing 57
Munich 52
Ann Arbor 51
Foggia 48
Bari 47
Hanoi 43
Los Angeles 43
Rome 43
Phoenix 34
São Paulo 32
Milan 29
Vienna 24
Nanchang 23
Des Moines 22
Brooklyn 21
North Bergen 21
Hudson 20
Nuremberg 20
Brussels 19
London 19
Naples 19
Shenyang 19
Frankfurt am Main 18
Kraków 18
San Mateo 18
Kunming 17
Orem 17
Buffalo 16
Seattle 16
Atlanta 15
Tokyo 15
Agrolândia 14
Boardman 14
Chicago 14
Gravina in Puglia 14
Haiphong 14
Hebei 14
Houston 14
Mexico City 14
Norwalk 14
Bangkok 13
Gravina In Puglia 13
Jakarta 13
San Severo 13
Shanghai 13
Stevenage 13
Falkenstein 12
Tianjin 12
Boston 11
Caserta 11
Delhi 11
Hangzhou 11
San Francisco 11
Stockholm 11
Woodbridge 11
Düsseldorf 10
Hillsboro 10
Jiaxing 10
Montreal 10
Toronto 10
Turku 10
Zhengzhou 10
Baghdad 9
Belo Horizonte 9
Brno 9
Charlotte 9
Chennai 9
Manfredonia 9
Orange 9
Tashkent 9
Assago 8
Biên Hòa 8
Bologna 8
Cagliari 8
Changsha 8
Guangzhou 8
Las Vegas 8
New Providence 8
Totale 6.940
Salva come PNG Salva come JPEG
Nome #
Direct-acting antivirals (daas) increase the serum vegf level in patients with chronic hepatitis c: a rationale for tumor recurrence 338
Ulcere da decubito, prevenzione e trattamento. 207
Strategie per la gestione del paziente HBV+ in terapia con immunosoppressori 205
Liver toxicity induced by amiodarone is dependent on mitochondria Complex I impairment, OXPHOS uncoupling and cardiolipin peroxidation. 186
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 176
Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet 162
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 162
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 161
To be or not to be: A two years surveillance for a CA 19-9 persistent elevation before cancer diagnosis and bone metastases 156
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 151
Diagnostic reliability of the procalcitonin serum marker in septic frail patient 147
Effects of dietary fatty acids and cholesterol excess on liver injury: a lipidomic approach 145
Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials 140
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 140
Amiodarone induces liver toxicity by impairing liver mitochondria bioenergetics and redox balance. 137
Analogs in the treatment of chronic hepatitis B: real life experience with tenofovir and entecavir 137
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 135
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry 130
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients with Circulating Cryoglobulins 129
Efficacy and safety of direct-acting antivirals in elderly with chronic hepatitis C: results from a retrospective cohort study 129
Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications 127
Improved risk stratification of patients with atrial fibrillation: An integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation 124
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 123
Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice 119
Biopsychosocial predictors of interferon-related depression in patients with Hepatitis C 118
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 117
A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model 117
High prevalence of false positive SARS-CoV2 serology in a cohort of patients with liver autoimmune diseases 116
Krebs cycle derivatives, dimethyl fumarate and itaconate, control metabolic reprogramming in inflammatory human microglia cell line 115
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis 114
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal 113
Direct-acting antivirals restore systemic redox homeostasis in chronic HCV patients (Q1 WoS) 112
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 111
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation (Q1 WoS) 111
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 110
Asymptomatic saccular portal vein aneurysm: a case report and review of the literature 107
Low Diagnostic Accuracy of Transthoracic Ultrasound for the Assessment of Spontaneous Pneumothorax in the Emergency Setting: A Multicentric Study 106
HOW OFTEN HAVE WE SAID: IF I HAD THOUGHT OF IT BEFORE? 105
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 105
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 104
Age, mitochondria and bladder cancer 104
Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease 104
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 104
Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues 103
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 103
Treatment of chronic HCV infection in the era of protease inhibitors 102
Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry 102
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 102
Convergence of disciplines: a systematic review of multidisciplinary development approaches in artificial intelligence 101
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation 100
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 100
Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: Analysis of 944 patients in Apulia, Italy 100
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy 100
A Review on Biological Effects of Ultrasounds: Key Messages for Clinicians 98
Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease 98
Monocyte bioenergetics: An immunometabolic perspective in metabolic dysfunction-associated steatohepatitis 96
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? 96
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 96
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 95
Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary 94
Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry 94
Molecular mechanisms involved in HCC recurrence after direct-acting antiviral therapy 94
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients 94
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation 93
Serum lipid profile in HCV patients treated with direct-acting antivirals: a systematic review and meta-analysis 92
Unmet clinical questions in elderly patients with locally advanced and metastatic bladder cancer 89
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease 88
Assessing the impact of COVID-19 on liver cancer management (CERO-19) 88
Oxysterols and redox signaling in the pathogenesis of non alcoholic fatty liver disease. 87
Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 87
Prevalence and risk factors for hospital-acquired anemia in internal medicine patients: learning from the "less is more" perspective 86
Two-Dimensional Shear Wave Elastography Versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C 86
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry 84
Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry 84
The GLP-1 receptor agonist Exendin-4 modulates hippocampal NMDA-receptor signalling in aged rats and improves cognitive impairment in diabetic elderly patients 83
Low dose aspirin and clinical outcomes in patients with SARS-CoV-2 pneumonia: a propensity score-matched cohort analysis from the National SIMI‑COVID‑19 Registry 83
Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression (Q1 WoS) 83
Direct-acting antivirals for HCV treatment in older patients: A systematic review and meta-analysis 82
In-hospital mortality and length of stay in cirrhotic patients with sepsis treated with non-selective beta-blockers 82
Pseudocirrhosis and portal hypertension in patients with metastatic cancers: a systematic review and meta-analysis 81
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 81
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease 80
The glucose metabolic pathway as a potential target for therapeutics: Crucial role of glycosylation in alzheimer’s disease 80
Eradication of HCV by direct antiviral agents restores mitochondrial function and energy homeostasis in peripheral blood mononuclear cells 80
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 79
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? 78
Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes 77
The dual role of glutamatergic neurotransmission in Alzheimer’s disease: From pathophysiology to pharmacotherapy 77
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes 76
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 74
Contrast-Enhanced Ultrasound in Distinguishing between Malignant and Benign Peripheral Pulmonary Consolidations: The Debated Utility of the Contrast Enhancement Arrival Time 73
Lipid metabolism in development and progression of hepatocellular carcinoma 73
Pharmacological and toxicological effects of phytocannabinoids and recreational synthetic cannabinoids: Increasing risk of public health 73
Exploring the Relationship between Epicardial Fat Thickness and Coronary Revascularization: Implications for Cardiovascular Health 72
THU-323-Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes 68
US-GUIDED PROBE POSITIONING DOES NOT IMPROVE APPLICABILITY BUT REDUCES VARIABILITY IN LIVER STIFFNESS (FIBROSCAN) MEASUREMENT 67
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 66
Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry 65
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients 64
INSULINEMIC RESPONSE CURVE AFTER ORAL GLUCOSE TOLERANCE TEST IDENTIFIES EARLY ALTERATIONS OF GLUCOSE METABOLISM IN PATIENTS AFFECTED BY CHRONIC LIVER DISEASE 63
Totale 10.751
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022495 0 0 0 10 45 35 38 40 86 93 27 121
2022/20231.979 209 85 89 51 85 159 28 152 1.017 17 49 38
2023/2024425 55 46 16 20 28 90 17 29 7 4 9 104
2024/20251.851 121 14 52 62 75 215 223 117 450 127 223 172
2025/20264.351 231 301 462 461 310 253 846 479 319 331 167 191
2026/20271.387 125 358 380 524 0 0 0 0 0 0 0 0
Totale 12.467